Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis (vol 73, pg 516, 2014)

被引:0
|
作者
Nam, J. L.
Ramiro, S.
Gaujoux-Viala, C.
机构
关键词
D O I
10.1136/annrheumdis-2013-204577corr1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:320 / 320
页数:1
相关论文
共 50 条
  • [1] Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis
    Nam, Jackie L.
    Ramiro, Sofia
    Gaujoux-Viala, Cecile
    Takase, Kaoru
    Leon-Garcia, Mario
    Emery, Paul
    Gossec, Laure
    Landewe, Robert
    Smolen, Josef S.
    Buch, Maya H.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (03) : 516 - 528
  • [2] Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis
    Nam, Jackie L.
    Takase-Minegishi, Kaoru
    Ramiro, Sofia
    Chatzidionysiou, Katerina
    Smolen, Josef S.
    van der Heijde, Desiree
    Bijlsma, Johannes W.
    Burmester, Gerd R.
    Dougados, Maxime
    Scholte-Voshaar, Marieke
    van Vollenhoven, Ronald
    Landewe, Robert
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (06) : 1108 - 1113
  • [3] Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
    Gaujoux-Viala, Cecile
    Nam, Jackie
    Ramiro, Sofia
    Landewe, Robert
    Buch, Maya H.
    Smolen, Josef S.
    Gossec, Laure
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (03) : 510 - 515
  • [4] EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
    Smolen, Josef S.
    Landewe, Robert
    Breedveld, Ferdinand C.
    Buch, Maya
    Burmester, Gerd
    Dougados, Maxime
    Emery, Paul
    Gaujoux-Viala, Cecile
    Gossec, Laure
    Nam, Jackie
    Ramiro, Sofia
    Winthrop, Kevin
    de Wit, Maarten
    Aletaha, Daniel
    Betteridge, Neil
    Bijlsma, Johannes W. J.
    Boers, Maarten
    Buttgereit, Frank
    Combe, Bernard
    Cutolo, Maurizio
    Damjanov, Nemanja
    Hazes, Johanna M. W.
    Kouloumas, Marios
    Kvien, Tore K.
    Mariette, Xavier
    Pavelka, Karel
    van Riel, Piet L. C. M.
    Rubbert-Roth, Andrea
    Scholte-Voshaar, Marieke
    Scott, David L.
    Sokka-Isler, Tuulikki
    Wong, John B.
    van der Heijde, Desiree
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (03) : 492 - 509
  • [5] Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA
    Nam, J. L.
    Winthrop, K. L.
    van Vollenhoven, R. F.
    Pavelka, K.
    Valesini, G.
    Hensor, E. M. A.
    Worthy, G.
    Landewe, R.
    Smolen, J. S.
    Emery, P.
    Buch, M. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (06) : 976 - 986
  • [6] Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of The EULAR recommendations for the management of rheumatoid arthritis
    Chatzidionysiou, Katerina
    Emamikia, Sharzad
    Nam, Jackie
    Ramiro, Sofia
    Smolen, Josef
    van der Heijde, Desiree
    Dougados, Maxime
    Bijlsma, Johannes
    Burmester, Gerd
    Scholte, Marieke
    van Vollenhoven, Ronald
    Landewe, Robert
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (06) : 1102 - 1107
  • [7] Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis
    Gaujoux-Viala, Cecile
    Smolen, Josef S.
    Landewe, Robert
    Dougados, Maxime
    Kvien, Tore K.
    Martin Mola, Emilio
    Scholte-Voshaar, Marieke
    van Riel, Piet
    Gossec, Laure
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (06) : 1004 - 1009
  • [8] Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis
    Knevel, R.
    Schoels, M.
    Huizinga, T. W. J.
    Aletaha, D.
    Burmester, G. R.
    Combe, B.
    Landewe, R. B.
    Smolen, J. S.
    Sokka, T.
    van der Heijde, D. M. F. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (06) : 987 - 994
  • [9] EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
    Smolen, Josef S.
    Landewe, Robert B. M.
    Bergstra, Sytske Anne
    Kerschbaumer, Andreas
    Sepriano, Alexandre
    Aletaha, Daniel
    Caporali, Roberto
    Edwards, Christopher John
    Hyrich, Kimme L.
    Pope, Janet E.
    de Souza, Savia
    Stamm, Tanja A.
    Takeuchi, Tsutomu
    Verschueren, Patrick
    Winthrop, Kevin L.
    Balsa, Alejandro
    Bathon, Joan M.
    Buch, Maya H.
    Burmester, Gerd R.
    Buttgereit, Frank
    Cardiel, Mario Humberto
    Chatzidionysiou, Katerina
    Codreanu, Catalin
    Cutolo, Maurizio
    den Broeder, Alfons A.
    El Aoufy, Khadija
    Finckh, Axel
    Fonseca, Joao Eurico
    Gottenberg, Jacques-Eric
    Haavardsholm, Espen A.
    Iagnocco, Annamaria
    Lauper, Kim
    Li, Zhanguo
    McInnes, Iain B.
    Mysler, Eduardo F.
    Nash, Peter
    Poor, Gyula
    Ristic, Gorica G.
    Rivellese, Felice
    Rubbert-Roth, Andrea
    Schulze-Koops, Hendrik
    Stoilov, Nikolay
    Strangfeld, Anja
    van der Helm-van Mil, Annette
    van Duuren, Elsa
    Vliet Vlieland, Theodora P. M.
    Westhovens, Rene
    van der Heijde, Desiree
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (01) : 3 - 18
  • [10] EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
    Smolen, Josef S.
    Landewe, Robert B. M.
    Bijlsma, Johannes W. J.
    Burmester, Gerd R.
    Dougados, Maxime
    Kerschbaumer, Andreas
    McInnes, Iain B.
    Sepriano, Alexandre
    van Vollenhoven, Ronald F.
    de Wit, Maarten
    Aletaha, Daniel
    Aringer, Martin
    Askling, John
    Balsa, Alejandro
    Boers, Maarten
    den Broeder, Alfons A.
    Buch, Maya H.
    Buttgereit, Frank
    Caporali, Roberto
    Cardiel, Mario Humberto
    De Cock, Diederik
    Codreanu, Catalin
    Cutolo, Maurizio
    Edwards, Christopher John
    van Eijk-Hustings, Yvonne
    Emery, Paul
    Finckh, Axel
    Gossec, Laure
    Gottenberg, Jacques-Eric
    Hetland, Merete Lund
    Huizinga, Tom W. J.
    Koloumas, Marios
    Li, Zhanguo
    Mariette, Xavier
    Mueller-Ladner, Ulf
    Mysler, Eduardo F.
    da Silva, Jose A. P.
    Poor, Gyula
    Pope, Janet E.
    Rubbert-Roth, Andrea
    Ruyssen-Witrand, Adeline
    Saag, Kenneth G.
    Strangfeld, Anja
    Takeuchi, Tsutomu
    Voshaar, Marieke
    Westhovens, Rene
    van der Heijde, Desiree
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (06) : 685 - 699